Chemokine ligand-receptor interactions critically regulate cutaneous wound healing. 2018

Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
Department of Dermatology, University Clinic Duesseldorf, 40225, Duesseldorf, Germany.

BACKGROUND Wound healing represents a dynamic process involving directional migration of different cell types. Chemokines, a family of chemoattractive proteins, have been suggested to be key players in cell-to-cell communication and essential for directed migration of structural cells. Today, the role of the chemokine network in cutaneous wound healing is not fully understood. Unraveling the chemokine-driven communication pathways in this complex process could possibly lead to new therapeutic strategies in wound healing disorders. METHODS We performed a systematic, comprehensive time-course analysis of the expression and function of a broad variety of cytokines, growth factors, adhesion molecules, matrixmetalloproteinases and chemokines in a murine cutaneous wound healing model. RESULTS Strikingly, chemokines were found to be among the most highly regulated genes and their expression was found to coincide with the expression of their matching receptors. Accordingly, we could show that resting and activated human primary keratinocytes (CCR3, CCR4, CCR6, CXCR1, CXCR3), dermal fibroblasts (CCR3, CCR4, CCR10) and dermal microvascular endothelial cells (CCR3, CCR4, CCR6, CCR8, CCR9, CCR10, CXCR1, CXCR2, CXCR3) express a distinct and functionally active repertoire of chemokine receptors. Furthermore, chemokine ligand-receptor interactions markedly improved the wound repair of structural skin cells in vitro. CONCLUSIONS Taken together, we here present the most comprehensive analysis of mediators critically involved in acute cutaneous wound healing. Our findings suggest therapeutic approaches for the management of wound closure by targeting the chemokine network.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018925 Chemokines Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif. Chemokine,Chemotactic Cytokine,Chemotactic Cytokines,Cytokines, Chemotactic,Intercrine,Intercrines,Cytokine, Chemotactic

Related Publications

Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
June 2017, Journal of medicinal chemistry,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
February 1985, Journal of the American Academy of Dermatology,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
September 2002, The Journal of clinical investigation,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
September 1999, The New England journal of medicine,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
January 2007, Journal of burn care & research : official publication of the American Burn Association,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
January 2004, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
January 1993, Advances in experimental medicine and biology,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
February 1998, Biochemistry,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
November 2004, Biochemical and biophysical research communications,
Erich Bünemann, and Norman-Philipp Hoff, and Bettina Alexandra Buhren, and Ulrike Wiesner, and Stephan Meller, and Edwin Bölke, and Anja Müller-Homey, and Robert Kubitza, and Thomas Ruzicka, and Albert Zlotnik, and Bernhard Homey, and Peter Arne Gerber
August 2011, Experimental dermatology,
Copied contents to your clipboard!